CVRx to Present at the William Blair 46th Annual Growth Stock Conference
CVRx to Present at the William Blair 46th Annual Growth Stock Conference
CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy
CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy
Down 31.7% in 4 Weeks, Here's Why You Should You Buy the Dip in CVRx (CVRX)
CVRx, Inc. (CVRX) Q1 2026 Earnings Call Transcript
CVRx Q1 Earnings Call Highlights
CVRx (CVRX) Reports Q1 Loss, Beats Revenue Estimates
CVRx Reports First Quarter 2026 Financial and Operating Results
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
CVRx (CVRX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026
CVRx Announces Nomination of Michael Dale for Election to the Board of Directors
CVRx, Inc. Investigated by the Portnoy Law Firm
Reviewing Orthofix Medical (NASDAQ:OFIX) and CVRx (NASDAQ:CVRX)
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Continues – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
CVRx, Inc. (CVRX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
CVRx, Inc. (CVRX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
CVRx, Inc. (CVRX) Q4 2025 Earnings Call Transcript
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates
CVRx Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
CVRX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving CVRx Inc.
CVRx ALERT: Bragar Eagel & Squire, P.C. is Investigating CVRx Inc. on Behalf of CVRx Stockholders and Encourages Investors to Contact the Firm
CVRx INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. – CVRX
CVRx Kicks Off One Of The Largest Heart Device Trials In History
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
CVRx, Inc. (NASDAQ:CVRX) Given Average Recommendation of “Moderate Buy” by Analysts
CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
CVRx (NASDAQ:CVRX) Stock Price Down 9.9% – Here’s What Happened
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance
CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy
CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference
CVRx, Inc. (NASDAQ:CVRX) Given Average Recommendation of “Moderate Buy” by Analysts
CVRx (NASDAQ:CVRX) versus Bluejay Diagnostics (NASDAQ:BJDX) Critical Comparison
CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference
CVRx, Inc. (CVRX) Q3 2025 Earnings Call Transcript
CVRx (CVRX) Reports Q3 Loss, Beats Revenue Estimates
CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025